1.0103
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Trinity Biotech Plc Adr Borsa (TRIB) Ultime notizie
Trinity Biotech stock rises on successful CGM calibration-free trial - Investing.com
Trinity Biotech reports positive results for calibration-free CGM By Investing.com - Investing.com South Africa
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Trinity Biotech (TRIB) to Release Earnings on Wednesday - Defense World
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com India
Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service - GlobeNewswire Inc.
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com India
Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Trinity Biotech Secures Additional $4 Million in Debt Financing to Advance Continuous Glucose Monitoring Technology and Transformation Plan - Nasdaq
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech regains Nasdaq compliance - Investing.com
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com India
Global Blood Testing Market Size & Outlook, 2024-2030 - Grand View Research
Trinity Biotech to Implement ADS Ratio Change By Investing.com - Investing.com India
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo - Yahoo Finance
TRIB News Today | Why did Trinity Biotech stock go up today? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Investors in health-care stocks get rich as M&A booms - MarketWatch
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling - Insider Monkey
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):